Skip to content

MARIZYME, INC.

CIK 0001413754

← back to feed
Revenue (TTM)
$528.1K
+176.6% YoY Q3 Mar 2025
Net Income (TTM)
−$41.34M
−162.0% YoY Q3 Mar 2025
EPS Diluted (TTM)
−$0.69
−163.8% YoY Q3 Mar 2025
Gross Margin
71.7%
Q3 Mar 2025
Operating Margin
-1,737.1%
Q3 Mar 2025
Net Margin
-7,827.8%
Q3 Mar 2025
Free Cash Flow (TTM)
−$9.01M
Q3 Mar 2025
Cash
$329.81K
Q3 Mar 2025
Total Debt
$1.03M
Q3 Mar 2025
Shares Outstanding
131.79M sh
Q3 Mar 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings